<DOC>
	<DOC>NCT00263159</DOC>
	<brief_summary>The objective of this study is to evaluate the therapeutic effectiveness and cost-effectivity of pharmaceutical care for asthma patients.</brief_summary>
	<brief_title>Pharmaceutical Care for Asthma Control Improvement (PHARMACI)-Study</brief_title>
	<detailed_description>The objective of this study is to evaluate the therapeutic effectiveness and cost-effectivity of pharmaceutical care for asthma patients. Patients will be randomly allocated to the control group (= no input from pharmacist) or intervention group (= with pharmaceutical care at baseline and follow-up visits over 6 months).</detailed_description>
	<mesh_term>Asthma</mesh_term>
	<criteria>Patients with persistent asthma Asthma treatment for at least 12 months Regular visitors of the participating community pharmacy Severe comorbidity &gt; 10 packyears smoking history Asthma Control Test score &lt; 15 or =25</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>December 2007</verification_date>
</DOC>